Volume 17, Number 3—March 2011
CME ACTIVITY - Research
Staphylococcus aureus Infections in US Veterans, Maryland, USA, 1999–20081
LaRee A. Tracy
, Jon P. Furuno, Anthony D. Harris, Mary Singer, Patricia Langenberg, and Mary-Claire Roghmann
, Jon P. Furuno, Anthony D. Harris, Mary Singer, Patricia Langenberg, and Mary-Claire Roghmann
Table 1
Characteristics of Staphylococcus aureus infections, Veterans Affairs Maryland Health Care System, fiscal years 1999–2008*
| Characteristic | Invasive S. aureus infections |
Noninvasive S. aureus infections |
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total, n = 858 | Onset |
Susceptibility |
Total, n = 2,816 | Onset |
Susceptibility† |
||||||||
| H, n = 381 | C, n = 477 | MRSA, n = 449 | MSSA, n = 409 | H, n = 778 | C, n = 2,038 | MRSA, n = 1,807 | MSSA, n = 1,006 | ||||||
| No. patients | 800 | 359 | 441 | 415 | 385 | 2,511 | 708 | 1,803 | 1,600 | 908 | |||
| Age, y‡ | |||||||||||||
| Mean (SD) | 64 (14) | 67 (13) | 61 (13) | 65 (13) | 62 (14) | 62 (14) | 68 (13) | 60 (14) | 62 (14) | 62 (14) | |||
| Median | 64 | 70 | 60 | 65 | 61 | 61 | 71 | 58 | 61 | 60 | |||
| Range |
28–98 |
28–98 |
30–94 |
28–97 |
29–98 |
19–94 |
19–93 |
22–94 |
23–94 |
19–93 |
|||
| Male sex,
no. (%) |
782 (98) |
370 (97) |
469 (98) |
399 (98) |
440 (98) |
2,436 (97) |
691 (98) |
1,745 (97) |
1,552 (97) |
881 (97) |
|||
| Race, no. (%) | |||||||||||||
| Black | 393 (49) | 154 (43) | 239 (54) | 190 (48) | 203 (53) | 1,212 (48) | 289 (41) | 923 (51) | 781 (49) | 429 (47) | |||
| White | 387 (48) | 200 (56) | 187 (42) | 217 (52) | 170 (44) | 1,186 (47) | 412 (58) | 774 (43) | 745 (47) | 440 (49) | |||
| Other§ | 20 (3) | 5 (1) | 15 (3) | 8 (2) | 12 (3) | 113 (5) | 7 (1) | 106 (6) | 74 (5) | 39 (4) | |||
*MRSA, methicillin-resistant S. aureus. MSSA, methicillin-susceptible S. aureus; H, hospital; C, community.
†Methicillin-susceptibility unknown for 3 patients with noninvasive S. aureus infections.
‡Age unknown for 8 patients with noninvasive S. aureus infections.
§Includes missing data. Other/unknown race not included in test.
1This study was presented in part at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; 2009 Sep 11–15; San Francisco, California, USA (abstracts 1217 and 3136).
Page created: September 01, 2011
Page updated: September 01, 2011
Page reviewed: September 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.